Abstract:Abstract Background Mucus production is a process involved in the pathogenesis of Community-acquired pneumonia (CAP). The study is to determine Mucin 5B (MUC5B) protein concentration and its proportion in the bronchoalveolar lavage fluid (BALF) of CAP patients and evaluate its value to help assess disease severity. Methods A total of 118 patients were enrolled in this cross-sectional study, including 45 with severe CAP (SCAP) and 73 with non-severe CAP (NSCAP). MUC5B concentration in BALF were determined by immunoblotting analysis. Total protein concentration of BALF was detected by Pierce BCA kit. Cytokines IL6, IL10, IFNγ, IL13, and IL17 in BALF were measured using commercial enzyme-linked immunosorbent assay (ELISA). Spearman’s correlation analysis was applied to evaluate the relationships between MUC5B concentration or MUC5B/total protein ratio and the CURB-65 score, as well as cytokines. Logistic regression analysis was used to identify the independent factors associated with severe CAP. Receiver operating characteristic (ROC) curve was used to evaluate the assessment value of MUC5B/total protein ratio and other indexes for CAP severity. Results MUC5B concentration in the BALF of NSCAP group was higher than that in SCAP group [NSCAP 13.56 μg/ml (IQR 5.92–25.79) vs. SCAP 8.20 μg/ml (IQR 4.97–14.03), p = 0.011]. The total protein concentration in the BALF of NSCAP group was lower than that in SCAP group [NSCAP 0.38 mg/ml (IQR 0.15–1.10) vs. SCAP 0.68 mg/ml (IQR 0.46–1.69), p = 0.002]. The MUC5B/total protein ratio was remarkably higher in NSCAP group than that in SCAP groups [NSCAP 3.66% (IQR 1.50–5.56%) vs. SCAP 1.38% (IQR 0.73–1.76%), p < 0.001]. MUC5B/total protein ratio was negatively correlated with total protein concentration (r s = − 0.576, p < 0.001), IL6 (r s = − 0.312, p = 0.001), IL10 (r s = − 0.228, p = 0.013), IL13 (r s = − 0.183, p = 0.048), IL17 (r s = − 0.282, p = 0.002) and CURB-65 score (r s = − 0.239, p = 0.009). Logistic regression identified that MUC5B/total protein ratio, IL6 level and CURB-65 score as independent variables related to CAP severity. ROC curve demonstrated best assessment value of MUC5B/total protein ratio for SCAP (AUC 0.803, p < 0.001), with a sensitivity of 88.9% and a specificity of 64.4%. Conclusions Respiratory MUC5B disproportion is related to CAP severity. MUC5B/total protein ratio may serve as an assessment marker and a potential therapeutic target for severe CAP.

The Characteristics and Clinical Significance of Mucin Levels in Bronchoalveolar Lavage Fluid of Patients with Interstitial Lung Disease.

Serum MUC5AC Protein Levels Are Correlated with the Development and Severity of Connective Tissue Disease-Associated Pulmonary Interstitial Lesions

Studies on IL-8 and GM-CSF BALF of Patients with ALI

Altered Cytokine Levels In Bronchoalveolar Lavage Fluids From Patients With Mycoplasma Pneumonia Infection

Elevated Serum Levels Of Mucin-Associated Antigen In Patients With Acute Respiratory Distress Syndrome

The clinical significance of IgG4 in the bronchoalveolar lavage fluid of rheumatic disease related interstitial lung disease

Expression and clinical significance of biomarkers in serum and bronchoalveolar lavage fluid from patients with connective tissue disease-associated interstitial lung disease

Microbiome features in bronchoalveolar lavage fluid of patients with idiopathic inflammatory myopathy-related interstitial lung disease

Expression and Clinical Significance of Mucoprotein MUC5AC in Patients with Chronic Obstructive Pulmonary Disease

Airway IL-1β is related to disease severity and mucociliary function in bronchiectasis

Airway inflammation and macrophage inflammatory protein-1α, gelatinase B level in patients with COPD

Interleukin-31 Expression and Relation to Disease Severity in Human Asthma.

[The Clinical Significance of the Levels of Serum KL-6 Mucin and Interleukin-13 in Pulmonary Alveolar Proteinosis].

Relationship Between the Level of MCP-1 Expression in Sera of RA Patients and ILD

Increased Concentrations of Soluble B7-H3 and Interleukin 36 in Bronchoalveolar Lavage Fluid of Children with Mycoplasma Pneumoniae Pneumonia

Expression of S100A9 and KL-6 in Common Interstitial Lung Diseases

Monitoring and Its Clinical Significance of SP-D and Interleukin-6 Levels in the Bronchoalveo-Lar Lavage Fluid of COPD Patients Undergoing Mechanical Ventilation

Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID‐19 patients

Level of IL-27 in Tuberculous Pleural Effusion and Its Clinical Implications

Application of Bronchoalveolar Lavage in Interstitial Pneumonia With Autoimmune Features and Connective Tissue Disease-associated Interstitial Lung Disease

Respiratory MUC5B disproportion is involved in severe community-acquired pneumonia